
Loading, please wait...

Loading, please wait...

Epidermal necrolysis sequelae represent a significant long-term burden for survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis. Recently, a comprehensive cohort study evaluated 129 adult patients to determine the prevalence and severity of these complications. Researchers discovered that 93.8% of participants suffered from at least one long-term issue. Furthermore, these results emphasize the necessity of moving beyond acute survival to focus on functional recovery and life quality.
Cutaneous and ocular complications are the most common outcomes, appearing in 76% and 71.3% of patients, respectively. Specifically, severe ocular damage often correlates with a diagnosis of toxic epidermal necrolysis (TEN). Additionally, other critical risk factors include the total number of involved mucous membranes and the length of the initial hospital stay. Moreover, cutaneous issues are more likely in patients who experienced higher percentages of skin detachment during the acute phase. Therefore, clinicians must prioritize early screening for these specific systems.
Psychological distress also plays a major role in the post-discharge period. Nearly 30% of survivors reported severe psychological symptoms, which notably hindered their return to professional life. Interestingly, these mental health outcomes were most strongly associated with a prior psychiatric history rather than the extent of the skin detachment. Because 48.9% of active patients could not return to work, the socio-professional impact is substantial. Consequently, integrating mental health support into the recovery plan is vital for successful rehabilitation.
Clustering analysis has identified three distinct patient profiles regarding complications. Some survivors experience mild or no issues, while others face severe cutaneous and pulmonary damage. The third group typically presents with multi-organ involvement, including ocular, oral, and genital sequelae. Furthermore, these diverse outcomes suggest that a \"one-size-fits-all\" approach is insufficient. Instead, a multidisciplinary and personalized follow-up strategy is essential to address the unique needs of each survivor. Personalized care plans can significantly mitigate the long-term burden of the disease.
One or more sequelae occur in approximately 93.8% of survivors. Cutaneous and ocular problems are the most frequent, affecting over 70% of the patient population.
The primary risk factors for severe ocular sequelae include a diagnosis of toxic epidermal necrolysis, involvement of multiple mucous membranes, and a prolonged hospital stay.
Psychological sequelae, such as depression and anxiety, affect nearly 30% of survivors. These conditions are often the leading cause of the inability to return to work following hospital discharge.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Nguyen TV et al. Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors. J Eur Acad Dermatol Venereol. 2026 Jun 04. doi: 10.1111/jdv.70547. PMID: 42241024.
Bettuzzi T et al. Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults. JAMA Dermatol. 2024;160(12):1288-1296. doi:10.1001/jamadermatol.2024.3575.
Sutedja E et al. Understanding the Gap Between Acute Complications and Long-Term Sequelae in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clin Cosmet Investig Dermatol. 2025;18:979-988. doi:10.2147/CCID.S514590.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study of 129 survivors found that 93.8% experience long-term epidermal necrolysis sequelae, including severe ocular and psychological impacts....
4 months ago

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday